Select a community
All Communities
Home > Community Treatment Reports > Quinidine/dextromethorphan Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Quinidine/dextromethorphan Treatment Report

Brand Names: Neurodex

What is Quinidine/dextromethorphan? Neurodex is a combination of 30mg Dextromethorphan (found in cough medicine) and 30mg Quinidine made by Avanir Phamaceuticals. In a randomised, multicentre control trial the combination of these two agents was found to halve episodes of emotional lability relative to either agent alone. Read more...Click to read more below

Avanir's Quinidine/dextromethorphan site


Reasons taken

12 patients in the community are taking or have taken Quinidine/dextromethorphan.

Reason # Patients Percentage of patients
Emotional lability 10 83%
disease-related symptoms 1 8%
Cramps 1 8%

Dosages

Based on the patients currently taking Quinidine/dextromethorphan.

  daily 40 mg daily 50 mg daily 60 mg daily 90 mg daily 105 mg daily
  4 Number of Patients: 4 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Quinidine/dextromethorphan or how long patients were taking Quinidine/dextromethorphan before stopping.

Currently Taking Quinidine/dextromethorphan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
0
4

Stopped Taking Quinidine/dextromethorphan

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
1
1
Why Patients Stopped Taking Quinidine/dextromethorphan (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense 1 50% Expense: 50%
Course of treatment ended 1 50% Course of treatment ended: 50%

Patient Reported Evaluations

Results from 1 patient evaluation. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

There is currently no efficacy data for Quinidine/dextromethorphan.

Side-effects (as an overall problem)

Severe 0% 0
Moderate 0% 0
Mild 0% 0
None 100% 1

Top reported side-effects include:

Summary results are based on 1 individual response. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 1)

  • ALS Boy
    Sex: M
    Mouth/throat: moderate
    Arms: moderate
    Chest: none
    Legs: moderate
  • ALS Boy
  • by ALS Boy
    Oct 20, 2008
  • EfficacyModerate
  • Side-effectsNone
  • Emotional lability

See all evaluation results for Quinidine/dextromethorphan

Report created on November 08, 2009.